Skip to main content
. 2012 Nov 1;6(6):1392–1397. doi: 10.1177/193229681200600619

Table 1.

Baseline Characteristicsa

HumaPen Memoir (N = 129) HumaPen Luxura (N = 128) Total (N = 257)
Age, years
Mean (SD) 38.3 (17.37) 41.2 (15.52) 39.8 (16.50)
Categories (%)
Adults (≥18 years) 109 (84.5) 117 (91.4) 226 (87.9)
Adolescents (12–17 years) 17 (13.2) 8 (6.3) 25 (9.7)
Children (8–11 years) 3 (2.3) 3 (2.3) 6 (2.3)
HbA1c at baseline, %
Mean (SD) 9.12 (1.04) 9.06 (0.94) 9.09 (0.99)
Sex, N (%)
Female 56 (43.4) 52 (40.6) 108 (42.0)
Male 73 (56.6) 76 (59.4) 149 (58.0)
Race, N (%)
White 128 (99.2) 127 (99.2) 255 (99.2)
Black or African American 1 (0.8) 1 (0.8) 2 (0.8)
Body mass index, kg/m2
Mean (SD) 26.75 (5.35) 26.78 (5.04) 26.77 (5.19)
Duration of diabetes, years
Mean (SD) 15.2 (11.46) 16.7 (10.95) 16.0 (11.21)
Daily basal insulin dose, IU/kg
Mean (SD) 0.38 (0.17) 0.41 (0.18) 0.39 (0.18)
Daily prandial insulin dose, IU/kg
Mean (SD) 0.41 (0.21) 0.45 (0.27) 0.43 (0.24)
Prandial injections per day, N (%)
1–2 injections 1 (0.8) 4 (3.1) 5 (2.0)
3 injections 114 (65.9) 77 (60.2) 162 (63.0)
4 injections 29 (22.5) 21 (24.2) 60 (23.3)
≥5 injections 14 (10.9) 16 (13.3) 30 (11.7)
a

N = total number of patients per group; N = number of evaluable patients.